FDA issues warning for compounded drugs from Cantrell Drug Company
Editor's Note The Food & Drug Administration (FDA) on March 2 issued a warning for healthcare professionals not to use drug products produced by Cantrell Drug Company (Little Rock, Arkansas), including opioids and other drugs intended for sterile injections. The FDA is concerned about serious deficiencies in Cantrellโs compounding operations,…
Multimodal pain management reduces opioid use, complications after total joints
Editor's Note Using a multimodal approach to pain management was associated with decreased opioid use, opioid prescriptions, and opioid complications in total joint replacement patients in this study. Of 512,393 hip replacement and 1,028,069 knee replacement patients analyzed, multimodal pain management techniques were used in 85.6% during surgery, on the…
Joint Commission updates sentinel event stats for 2017
Editor's Note The Joint Commission on February 28 announced the update of its sentinel event statistics for 2017. Of 805 reports reviewed, the Top 10 events most frequently reported included: unintended retention of a foreign bodyโ116 events (first place) wrong-patient, wrong-site, wrong-procedureโ95 events (third place) medication errorโ32 events (eighth place)…
Total hip linked to increased life expectancy
Editor's Note Total hip arthroplasty (THA) is not only associated with improved quality of life but with increased life expectancy, this Swedish study finds. Of 131,808 patients having THA from 1999 to 2012, survival was 1% better in the first year than those who did not have surgery. Survival increased…
FDA issues Safety Alert for clarithromycin
Editor's Note The Food and Drug Administration (FDA) on February 22 issued a Safety Alert for clarithromycin (Biaxin) because of the potential increased risk of heart problems or death associated with this antibiotic in patients with heart disease. A large clinical trial with 10-year follow-up found an unexpected increase in…
Study provides first standardized estimates of OR costs
Editor's Note Using financial data from Californiaโs short-term and specialty hospitals from FY 2005 to FY 2014, researchers from the UCLA School of Medicine provide the first standardized estimates of OR costs. The analysis, which focused on two revenue centers--surgery/recovery and ambulatory surgery--found that the mean cost of OR time…
CMS extends deadline for eCQM data, EHR incentive program submission
Editor's Note The Centers for Medicare & Medicaid Services (CMS) is notifying eligible hospitals and critical access hospitals that they now have until March 16 to attest for Medicare Electronic Health Record (EHR) Incentive Program requirements for CY 2017 and to submit electronic clinical quality measure (eCQM) data for the…
Agencies issue voluntary protocols for duodenoscope surveillance sampling, culturing
Editor's Note The Food & Drug Administration, Centers for Disease Control & Prevention (CDC), American Society for Microbiology, along with other experts on February 26 released voluntary standardized protocols for duodenoscope surveillance sampling and culturing, which update a 2015 CDC interim protocol. For facilities that choose to implement duodenoscope surveillance…
Study: Efficiency, safety of overlapping surgery
Editor's Note In this study to evaluate the efficiency and safety of overlapping surgery at the University of Alabama, Birmingham, researchers found that the practice does not expose patients to increased risk of negative outcomes. Of 26,260 cases analyzed for surgical time and 15,106 for outcomes, overlapping surgery patients had:…
Joint Commission: On-site, non-waived lab services must be accredited
Editor's Note The Joint Commission on February 26 posted a reminder that whenever non-waived laboratory services are provided on-site (either directly or through contract) within a Joint Commission accredited facility, a separate 2-year cycle laboratory accreditation survey must also be conducted either by the Joint Commission or one of its…